Intra- and interlaboratory variabilities of results obtained with the quantiplex human immunodeficiency virus type 1 RNA bDNA assay, version 3.0

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 3, 2001, Pages 560-563

  Kellogg, J A ^a   Atria, P V ^a   Sanders, J C ^a   Eyster, M E ^a  

^a YORK HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD SAMPLING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS LOAD;

BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; HIV INFECTIONS; HIV-1; HUMANS; REFERENCE VALUES; RNA, VIRAL;

EID: 0035002705     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.3.560-563.2001     Document Type: Article

References (18)

1. Methods, interpretation, and applications of HIV-1 viral load measurements
2. Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription polymerase chain reaction
3. Organization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR
4. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA Quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor Monitor version 1.5
5. Performance characteristics of the Quantiplex HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma
6. Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor Monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples
7. The clinical utility of viral quantitation using molecular methods
8. Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes
9. Determination of levels of human immunodeficiency virus type 1 RNA in plasma: Reassessment of parameters affecting assay outcome
10. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma
11. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma
12. Clinical and laboratory implications of acute HIV-1 infection
13. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: A case series
14. Biological and virologic characteristics of primary HIV infection
15. Multicenter comparison of three methods for quantification of human immunodeficiency virus type 1 RNA in plasma
16. Extensive evaluation of a seronegative participant in an HIV-1 vaccine trial as a result of false-positive PCR
17. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS clinical trials group virology laboratories